2019
DOI: 10.1002/ajmg.c.31694
|View full text |Cite
|
Sign up to set email alerts
|

Precision medicine in Thailand

Abstract: Extraordinary advances in high throughput next generation sequencing (NGS) technology and bioinformatics are the main thrust that transforms the current state of healthcare into the era of precision medicine where clinical practice takes individual variability into account. Here, we summarize the current status of the infrastructure we have and the adoption of precision medicine in Thailand in four spheres: rare diseases, oncology, pharmacogenomics, and noncommunicable diseases. Moreover, we provide our perspe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 66 publications
(68 reference statements)
0
13
0
Order By: Relevance
“…We collected ES data of 1119 unrelated Thai individuals recruited from six centers with majority located in the central region (Supplementary Table S1). In Thailand, we have limited number of clinical geneticists and majority of them are working in Bangkok 13,14 . Thus, most rare‐disease patients would attend hospitals in Bangkok either by walk‐in or via a referral system from their local healthcare providers.…”
Section: Resultsmentioning
confidence: 99%
“…We collected ES data of 1119 unrelated Thai individuals recruited from six centers with majority located in the central region (Supplementary Table S1). In Thailand, we have limited number of clinical geneticists and majority of them are working in Bangkok 13,14 . Thus, most rare‐disease patients would attend hospitals in Bangkok either by walk‐in or via a referral system from their local healthcare providers.…”
Section: Resultsmentioning
confidence: 99%
“…Further, Japan has used the project to develop a new database to archive pathogenic variants among Japanese patients showing the clinical benefit of large scale precision medicine projects. Thailand, on the other hand, shows how a self‐described “middle income” country can make significant progress in the world of precision medicine (Shotelersuk, Tongsima, Pithukpakorn, Eu‐ahsunthornwattana, & Mahasirimongkol, ). Their establishment of Thailand's Rare and Undiagnosed Disease Network (T‐RUN) which has performed more than 2000 WES and 150 WGS analyses, and the Thai Cancer Precision Medicine project exemplifies how with decreasing costs of NGS, the increasing ability to interpret the genomic data and the growing number of actionable and available treatments for genetic diseases, the implementation of precision medicine at the public health level in Asian countries is not a matter of if but when.…”
Section: Precision Medicine In Asiamentioning
confidence: 99%
“…However, the landscape of genetic testing in Thailand is on the brink of transformation. The Genomics Thailand Initiative (Shotelersuk et al, 2019), which is the Thai national initiatives in precision medicine and translational genomics sponsored by the Thai Government, will likely have a large impact on public perception of genetic services soon. The Genomics Thailand Initiative, in conjunction with the Thai Ministry of Public Health, is expanding clinical programs in genomics and precision medicine targeting cancer, rare hereditary diseases, and noncommunicable diseases in healthcare facilities throughout Thailand (Springer Nature, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…These consequences can be mitigated by healthcare professionals, particularly clinical geneticists, and genetic counselors, who can provide consultation and guide the public on how to navigate these complex issues. However, genetic services and personnel in Thailand remain very limited, with recent surveys showing that there were only 24 practicing clinical geneticists and no genetic counselor available for a country with a population of 70 million people (Limwongse, 2017;Shotelersuk et al, 2019). For this reason, the burden of increased needs for genetic counseling and services would likely fall on primary care physicians and internal medicine specialists.…”
Section: Introductionmentioning
confidence: 99%